Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SENSIENT TECHNOLOGIES CORP Director's Dealing 2010

Mar 3, 2010

31054_dirs_2010-03-03_177e4833-d6f3-4163-b37f-9f68f2ae5718.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SENSIENT TECHNOLOGIES CORP (SXT)
CIK: 0000310142
Period of Report: 2010-02-24

Reporting Person: CROFT JAMES AD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-24 Common Stock M 2000 $18.70 Acquired 20704.776 Direct
2010-02-24 Common Stock M 2000 $21.66 Acquired 22704.776 Direct
2010-02-24 Common Stock M 2000 $20.46 Acquired 24704.776 Direct
2010-02-24 Common Stock M 2000 $20.07 Acquired 26704.776 Direct
2010-02-24 Common Stock M 2000 $20.25 Acquired 28704.776 Direct
2010-02-24 Common Stock S 10000 $26.7852 Disposed 18704.776 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-24 Stock Options (Right to Buy) $18.70 M 2000 Disposed 2011-05-01 Common Stock (2000) Direct
2010-02-24 Stock Options (Right to Buy) $21.66 M 2000 Disposed 2013-05-01 Common Stock (2000) Direct
2010-02-24 Stock Options (Right to Buy) $20.46 M 2000 Disposed 2014-05-03 Common Stock (2000) Direct
2010-02-24 Stock Options (Right to Buy) $20.07 M 2000 Disposed 2015-05-02 Common Stock (2000) Direct
2010-02-24 Stock Options (Right to Buy) $20.25 M 2000 Disposed 2016-05-01 Common Stock (2000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1500 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to Buy) $25.19 2012-05-01 Common Stock (2000) 2000 Direct
Stock Options (Right to Buy) $26.12 2017-05-01 Common Stock (2000) 2000 Direct
Stock Options (Right to Buy) $30.07 2018-05-01 Common Stock (2000) 2000 Direct

Footnotes

F1: Exercise of in-the-money stock option that would otherwise expire on 5/1/2011, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F2: Includes shares of restricted stock held under Issuer's 2002 Non-Employee Director Stock Plan and shares held in a dividend reinvestment plan.

F3: Exercise of in-the-money stock option that would otherwise expire on 5/1/2013, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F4: Exercise of in-the-money stock option that would otherwise expire on 5/3/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F5: Exercise of in-the-money stock option that would otherwise expire on 5/2/2015, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F6: Exercise of in-the-money stock option that would otherwise expire on 5/1/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F7: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $26.66 to $26.90. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.